Loading clinical trials...
Loading clinical trials...
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JMKX003002 in Single and Multiple Ascending Dose Randomized，Doubled-blind Phase 1 Study in Healthy Subjects
Conditions
Interventions
JMKX003002 will be administered orally
JMKX003002 will be administered orally
+3 more
Locations
1
China
Huashan Hospital Fudan University
Shanghai, Shanghai Municipality, China
Start Date
May 9, 2023
Primary Completion Date
December 1, 2023
Completion Date
March 1, 2024
Last Updated
June 18, 2023
NCT01226316
NCT03010046
NCT03672604
NCT00854113
NCT01907867
NCT01495169
Lead Sponsor
Jemincare
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions